Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Proteostasis imbalance is emerging as a major hallmark of cancer, driving tumor aggressiveness. Evidence suggests that the endoplasmic reticulum (ER), a major site for protein folding and quality control, plays a critical role in cancer development. This concept is valid in glioblastoma multiform (GBM), the most lethal primary brain cancer with no effective treatment. We previously demonstrated that the ER stress sensor IRE1α (referred to as IRE1) contributes to GBM progression, through XBP1 mRNA splicing and regulated IRE1-dependent decay (RIDD) of RNA Here, we first demonstrated IRE1 signaling significance to human GBM and defined specific IRE1-dependent gene expression signatures that were confronted to human GBM transcriptomes. This approach allowed us to demonstrate the antagonistic roles of XBP1 mRNA splicing and RIDD on tumor outcomes, mainly through selective remodeling of the tumor stroma. This study provides the first demonstration of a dual role of IRE1 downstream signaling in cancer and opens a new therapeutic window to abrogate tumor progression.

Original publication

DOI

10.15252/emmm.201707929

Type

Journal article

Journal

Embo molecular medicine

Publication Date

03/2018

Volume

10

Addresses

Université de Bordeaux, Bordeaux, France.

Keywords

Cell Line, Tumor, Humans, Glioblastoma, Brain Neoplasms, Endoribonucleases, Neoplasm Proteins, RNA, Messenger, Signal Transduction, Gene Expression Regulation, Neoplastic, RNA Splicing, Phenotype, Mutation, Models, Biological, Tumor Microenvironment, Carcinogenesis, Protein Serine-Threonine Kinases